Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis
October 10, 2023 16:37 ET
|
Novo Nordisk A/S
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis Bagsværd, Denmark, 10 October 2023 – Novo Nordisk today announced the decision to...
Novo Nordisk A/S - share repurchase programme
October 09, 2023 07:14 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 09 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
October 02, 2023 08:11 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 02 October 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
September 25, 2023 11:07 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 25 September 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
September 25, 2023 08:00 ET
|
Novo Nordisk A/S
Collaboration will apply Valo’s Opal Computational Platform™ and real-world patient dataset to enable the discovery and development of novel cardiometabolic drug programmes Novo Nordisk licenses...
Novo Nordisk and UNICEF to extend joint initiative to prevent global childhood obesity
September 20, 2023 14:58 ET
|
Novo Nordisk A/S
New York and Bagsværd, 20 September 2023 – Novo Nordisk and UNICEF today announced an extension of their long-term partnership to help prevent global childhood overweight and obesity - a public health...
Novo Nordisk A/S - share repurchase programme
September 18, 2023 07:36 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 18 September 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
September 13, 2023 11:33 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 13 September 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk conducts a two-for-one stock split
September 13, 2023 01:30 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 13 September 2023 – As communicated on 10 August 2023 in connection with the release of Novo Nordisk's financial results for the first six months of 2023, Novo Nordisk's Board of...
Novo Nordisk A/S - share repurchase programme
September 04, 2023 08:12 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 4 September 2023 – On 10 August 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...